PD-L1 expression in breast cancer has been frequently evaluated in recent studies, most of which have used tissue microarrays (TMAs) due to their large sample sizes and including a variety of breast cancer subtypes [4, 20]. This evidence concerns the gene CD274 and breast carcinoma.